CLARK ESTATES INC/NY

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1056466 NEW YORK, NY

Position in HALO

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$3,511,818

+$612,000 QoQ

Shares Held

44,868

0.0% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

1.04%

of 13F equity value

Holder Rank

#40

of 287 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CLARK ESTATES INC/NY holds $19,231,309 across 5 Biotechnology names. HALO ranks #2 (18.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	STTK	Shattuck Labs, Inc.	1,430,167	$9,925,358
2	HALO	Halozyme Therapeutics, Inc. This page	44,868	$3,511,818
3	HRMY	Harmony Biosciences Holdings, Inc.	81,300	$2,960,133
4	INCY	Incyte Corp	25,000	$2,834,000
5	CPRX	Catalyst Pharmaceuticals, Inc.	113,918	$0

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,511,818	44,868	0.0%	Shares	Sole	2026-08-05
2026-03-31	$2,899,818	44,868	0.0%	Shares	Sole	2026-05-11
2025-12-31	$3,019,616	44,868	0.0%	Shares	Sole	2026-02-12
2025-09-30	$3,290,619	44,868	0.0%	Shares	Sole	2025-11-10
2025-06-30	$2,334,033	44,868	0.0%	Shares	Sole	2025-08-11
2025-03-31	$2,863,027	44,868	-27.6%	Shares	Sole	2025-05-08
2024-12-31	$2,964,220	62,000	—	Shares	Sole	2025-02-06
No filing history on record for this holder in this stock.